Details for New Drug Application (NDA): 020340
✉ Email this page to a colleague
The generic ingredient in TEMOVATE E is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 020340
Tradename: | TEMOVATE E |
Applicant: | Fougera Pharms |
Ingredient: | clobetasol propionate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020340
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jun 17, 1994 | TE: | RLD: | Yes |
Complete Access Available with Subscription